āagman

Not investment advice. Data and computed figures, for information only.

Marksans Pharma Ltd

NSE: MARKSANS
₹307.85
−₹6.30 (−2.01%)
NSE · 15 Oct 2026, close
As of 31 Mar 2026
Market Cap
₹14,007 Cr
CMP
₹307.85
52-wk High / Low
₹351 / 155
P/E
27.1
P/B
4.6
Book Value
₹66.7
Div Yield
0.29%
ROCE
19.0%
ROE
15.2%
Face Value
₹1
D/E
0.11

Price+69.5% over 1Y

āagman read

Computed by āagman
Derived from 12 years and 13 quarters of filings. Not reported by the company.
As of 15 Oct 2026
Piotroski F-Score
5
/ 9
5 of 9 F-score tests passed
Graham Number
₹118
√(22.5 × EPS × book value per share)
ROIC
11.2%
vs 11.2% sector median
Cash flow to profit
1.09
CFO / PAT
Above 1.0 = operating cash flow exceeded reported profit
Margin change
+920
bps OPM YoY
Operating margin vs the same quarter last year
Sustainable growth
14.0%
ROE × earnings retention ratio
ROE stability
0.6
pp σ
Standard deviation of ROE across periods. Lower = more stable
Holder deltas
QoQ
pp
Prom +0.00FII +0.71DII −0.38
Latest quarter vs the previous one
Cash-accrual divergence
−1.1%
of assets
Low = accruals track cash flow
Strengths
+ROCE has stayed above the sector median for 5 consecutive years (weakest: 19% vs the 2026 sector median of 17%)
+Price trades above its 200-day moving average (1.3x)
+FII holding rose by 2.4pp over the last year
+PE of 27.1x is below the sector median of 45.9x
Watch-outs
−Borrowings are up 243.0% since FY2016 (100 to 343)

Peer comparison

Peers
NameP/EMar Cap ₹ CrROCE %ROE %

Quarterly results

Consolidated basis (as filed) · ₹ Cr · 13 quarters
As of 30 Jun 2026
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales500531586560591642682708620720754856841
Expenses398417453450462495543582520576594661628
Operating Profit102114133110128147139127100144161195213
OPM %20.4%21.5%22.7%19.6%21.7%22.9%20.4%17.9%16.1%20.0%21.4%22.8%25.3%
Other Income10195171502815622203525
Interest2235333366667
Depreciation14182221202021232327242425
Profit before tax9711411310012012514311677133151200207
Net Profit708483788998105915899114149159
EPS (₹)1.521.841.841.731.962.132.312.001.292.172.503.273.47

Profit & Loss

As of 30 Jun 2026
Consolidated · ₹ Cr · 12 years + TTM
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales7978937679131,0001,1341,3761,4911,8522,1772,6232,9513,172
Expenses6127577228348689421,0371,2321,5131,7192,0902,3502,458
Operating Profit1851364578132192340259340459533601714
OPM %23.2%15.2%5.9%8.5%13.2%16.9%24.7%17.4%18.4%21.1%20.3%20.4%22.5%
Other Income39785074259506682102
Interest161071010988911122425
Depreciation162830272327364552748399100
Profit before tax1561071550104157302248338424504561691
Net Profit11283113680121239187265315383420521
EPS (₹)2.671.920.220.801.872.955.764.515.886.928.409.2211.41

Balance Sheet

As of 30 Jun 2026
Consolidated · ₹ Cr
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Jun 2026
Equity Capital414141414141414145454545—
Reserves3264013924305025958461,1611,7002,0202,4222,978—
Borrowings1011001101181003034111123244322343—
Other Liabilities207180209142160236307323322372451489—
Total Liabilities6767227527318029021,2281,6362,1902,6813,2403,856—
Fixed Assets1662702672792703033094284867769821,044—
CWIP0000001231092759—
Investments0000000012710—
Other Assets5104524844515335999071,2051,6941,8692,2302,753—
Total Assets6767227527318029021,2281,6362,1902,6813,2403,856—

Cash Flows

As of 31 Mar 2026
Consolidated · ₹ Cr
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity1553114502723317999237230207458
Cash from Investing Activity−33−123−21−39−13−60−45−84−259−141−49−249
Cash from Financing Activity17−58−33−21−114−1580198−69−65−71
Net Cash Flow138−150−1015−760118941762193138

Ratios

As of 31 Mar 2026
12 periods
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %44.023.04.010.018.025.038.023.022.021.020.019.0
ROE %———————————15.2
EPS (₹)2.671.920.220.801.872.955.764.515.886.928.409.22
Book Value (₹)———————————66.7
Face Value (₹)———————————1
P/E———————————27.1
Div Yield %———————————0.29
NPM %14.09.21.43.98.010.717.312.213.914.114.213.8
OPM %23.015.06.09.013.017.025.017.018.021.020.020.0
D/E0.280.230.250.250.180.050.040.090.070.120.130.11
P/B———————————4.6

Growth

As of 11 Oct 2026
Compounded sales growth
10 years+13.0%
5 years+16.0%
3 years+17.0%
TTM+20.0%
Compounded profit growth
10 years+18.0%
5 years+12.0%
3 years+16.0%
TTM+48.0%
Stock price CAGR
10 years+19.0%
5 years+35.0%
3 years+41.0%
Last year+70.0%
Return on equity
10 years17.0%
5 years17.0%
3 years16.0%
Last year15.0%

Shareholding pattern

As of 31 Mar 2026
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters48.25%48.25%48.25%48.25%48.25%48.25%48.25%43.85%43.85%43.87%43.87%43.87%
FIIs8.35%8.35%3.16%3.45%2.54%4.34%3.46%15.11%15.57%22.19%16.76%17.47%
DIIs0.28%0.28%1.74%0.62%0.89%0.34%0.47%1.46%5.17%4.55%6.57%6.19%
Government————————————
Public43.12%43.12%46.85%47.68%48.32%47.07%47.82%39.57%35.40%29.37%32.78%32.46%
No. of shareholders1,12,1141,12,1141,24,5961,27,1581,23,2151,35,2712,20,0901,98,3822,54,6992,57,2732,46,2792,46,635
Change since Jun 2023 (pp)
Promoters −4.38FIIs +9.12DIIs +5.91Public −10.66

Documents

As of 11 Oct 2026

Corporate actions

As of 20 Aug 2026
20 Aug 2026DIVIDENDDividend - Re 0.90 Per Share—
1 Aug 2025DIVIDENDDividend - Re 0.80 Per Share—
17 Sep 2024DIVIDENDDividend - Rs 0.60 Per Share—
7 Jun 2023DIVIDENDDividend - Re 0.50 Per Share—
19 Aug 2022DIVIDENDAnnual General Meeting/Dividend - Rs 0.25 Per Share—
15 Sep 2021DIVIDEND Annual General Meeting/Dividend - Rs 0.25 Per Share—
22 Sep 2020DIVIDEND Annual General Meeting/Dividend - Rs 0.10 Per Share—
19 Sep 2019DIVIDEND Annual General Meeting/Dividend - Rs 0.05 Per Share—
19 Sep 2018DIVIDEND Annual General Meeting/Dividend Re 0.05 Per Share—
19 Sep 2017DIVIDEND Annual General Meeting/Dividend - Re 0.05 Per Share—
22 Sep 2016DIVIDEND Annual General Meeting/Dividend - Re 0.12 Per Share—
23 Sep 2015DIVIDEND Annual General Meeting/ Dividend - Re 0.12/- Per Share—
18 Sep 2014DIVIDENDAnnual General Meeting / Dividend - Re 0.10/- Per Share—
Fundamentals from a third-party compiler of exchange filings; prices from the exchanges. Not investment advice.© 2026 āagman